Search results for: weight

ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

Susan Bernstein | March 1, 2013

Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment

ACR/ARHP Annual Meeting 2012: What Rheumatologists Need to Know about the New Oral Anticoagulants

Mary Beth Nierengarten | March 1, 2013

A hematologist outlines how the new drugs can help treat coagulation triggered by rheumatological diseases

Panel Addresses Drug Safety Issues in Rheumatology Products

Thomas R. Collins | February 15, 2013

Black box warnings, TNF inhibitors, and tofacitinib discussed

Coding Corner Question: February

Staff | February 1, 2013

Test your coding knowledge for an office visit for a 51-year-old female patient with osteoarthritis in her right knee who returns for a follow-up with the physician assistant six weeks after she received an intraarticular corticosteroid injection in her knee

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein | February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery

ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus

Susan Bernstein | February 1, 2013

Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE

Make Critical Electronic Health Record Decisions Now to Avoid Penalties and Maximize Incentives

Staff | January 25, 2013

Rheumatology practices of all sizes are considering the most cost-efficient and effective ways to achieve Meaningful Use.

Coding Corner Answer: January Coding Challenge

Staff | January 1, 2013

Identifying multiple determining factors—including prescription drug management, drug therapy, and chronic illness with severe exacerbation, progression, or side effects to treatment—in determining the level of risk in the medical decision making for a patient with rheumatoid arthritis

A Spotlight on IgG4-Related Disease

Emine Atac, MD, and John H. Stone, MD, MPH | January 1, 2013

What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)

Coding Corner Question: December

Staff | December 1, 2012

Test your coding knowledge for an office visit by a 60-year-old patient with severe rheumatoid arthritis who has an adverse reaction to an infliximab infusion, requiring her IV to be flushed with saline and pushed with diphenhydramine.